Dry Powder Inhaler Devices Market Report

Europe Dry Powder Inhaler Devices Market Size, Status and Forecast 2014-2026

  • POSTDATE：Nov 03, 2019
  • PAGES：224
  • REPORT CODE：GMM359451
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Dry Powder Inhaler Devices market was valued at 650 Million US$ in 2018 and is projected to reach 924 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.5% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Dry Powder Inhaler Devices Market Segmentations:

    By Player:

    • Respira Therapeutics, Inc

    • AKELA Pharma Inc

    • Cipla Inc

    • MannKind Corporation

    • Aespira Ltd

    • GlaxoSmithKline

    • Pharmaxis Limited

    • Teva Pharmaceutical Industries Ltd

    • Nanotherapeutics, Inc

    • Pharmaxis Limited

    • Sandoz International GmbH

    • OPKO Health, Inc

    • Shandong Jewim Pharmaceutical

    • Bayer HealthCare AG

    • Novartis AG

    By Type:

    • Single dose inhalers

    • Multi-dose inhalers

    • Storage dose inhalers

    By End-User:

    • Hospital use

    • Clinic use

    • Household

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dry Powder Inhaler Devices Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Single dose inhalers from 2014 to 2026

    • 1.3.2 Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Multi-dose inhalers from 2014 to 2026

    • 1.3.3 Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Storage dose inhalers from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Hospital use from 2014 to 2026

    • 1.4.2 Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Clinic use from 2014 to 2026

    • 1.4.3 Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Household from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Dry Powder Inhaler Devices Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dry Powder Inhaler Devices by Major Types

      • 3.4.1 Market Size and Growth Rate of Single dose inhalers

      • 3.4.2 Market Size and Growth Rate of Multi-dose inhalers

      • 3.4.3 Market Size and Growth Rate of Storage dose inhalers

    4 Segmentation of Dry Powder Inhaler Devices Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dry Powder Inhaler Devices by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Dry Powder Inhaler Devices for Hospital use

      • 4.4.2 Market Size and Growth Rate of Dry Powder Inhaler Devices for Clinic use

      • 4.4.3 Market Size and Growth Rate of Dry Powder Inhaler Devices for Household

    5 Market Analysis by Major Regions

    • 5.1 Europe Dry Powder Inhaler Devices Production Analysis by Top Regions

    • 5.2 Europe Dry Powder Inhaler Devices Consumption Analysis by Top Regions

    • 5.3 Europe Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.3 France Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    6 Product Circulation of Dry Powder Inhaler Devices Market among Top Countries

    • 6.1 Top 5 Export Countries in Dry Powder Inhaler Devices Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Dry Powder Inhaler Devices Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Dry Powder Inhaler Devices Landscape Analysis

    • 7.1 Germany Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 7.2 Germany Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    8. UK Dry Powder Inhaler Devices Landscape Analysis

    • 8.1 UK Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 8.2 UK Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    9. France Dry Powder Inhaler Devices Landscape Analysis

    • 9.1 France Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 9.2 France Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    10. Italy Dry Powder Inhaler Devices Landscape Analysis

    • 10.1 Italy Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 10.2 Italy Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    11. Spain Dry Powder Inhaler Devices Landscape Analysis

    • 11.1 Spain Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 11.2 Spain Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    12. Poland Dry Powder Inhaler Devices Landscape Analysis

    • 12.1 Poland Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 12.2 Poland Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    13. Russia Dry Powder Inhaler Devices Landscape Analysis

    • 13.1 Russia Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 13.2 Russia Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    14. Switzerland Dry Powder Inhaler Devices Landscape Analysis

    • 14.1 Switzerland Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 14.2 Switzerland Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    15. Turkey Dry Powder Inhaler Devices Landscape Analysis

    • 15.1 Turkey Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 15.2 Turkey Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Landscape Analysis by Top Countries

      • 16.3.1 Denmark Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 16.3.2 Finland Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 16.3.3 Norway Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 16.3.4 Sweden Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 16.3.6 Iceland Dry Powder Inhaler Devices Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Landscape Analysis by Top Countries

      • 17.3.1 Belgium Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 17.3.2 Netherlands Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 17.3.3 Luxembourg Dry Powder Inhaler Devices Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Landscape Analysis by Top Countries

      • 18.3.1 Estonia Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 18.3.2 Latvia Dry Powder Inhaler Devices Market Volume and Growth Rate

      • 18.3.3 Lithuania Dry Powder Inhaler Devices Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Respira Therapeutics, Inc

      • 19.1.1 Respira Therapeutics, Inc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 AKELA Pharma Inc

      • 19.2.1 AKELA Pharma Inc Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Cipla Inc

      • 19.3.1 Cipla Inc Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 MannKind Corporation

      • 19.4.1 MannKind Corporation Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Aespira Ltd

      • 19.5.1 Aespira Ltd Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 GlaxoSmithKline

      • 19.6.1 GlaxoSmithKline Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Pharmaxis Limited

      • 19.7.1 Pharmaxis Limited Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Teva Pharmaceutical Industries Ltd

      • 19.8.1 Teva Pharmaceutical Industries Ltd Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Nanotherapeutics, Inc

      • 19.9.1 Nanotherapeutics, Inc Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Pharmaxis Limited

      • 19.10.1 Pharmaxis Limited Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 Sandoz International GmbH

      • 19.11.1 Sandoz International GmbH Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 OPKO Health, Inc

      • 19.12.1 OPKO Health, Inc Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Shandong Jewim Pharmaceutical

      • 19.13.1 Shandong Jewim Pharmaceutical Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 Bayer HealthCare AG

      • 19.14.1 Bayer HealthCare AG Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Novartis AG

      • 19.15.1 Novartis AG Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    The List of Tables and Figures (Totals 66 Figures and 122 Tables)

    • Figure Product Picture

    • Figure Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Single dose inhalers from 2014 to 2026

    • Figure Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Multi-dose inhalers from 2014 to 2026

    • Figure Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Storage dose inhalers from 2014 to 2026

    • Figure Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Hospital use from 2014 to 2026

    • Figure Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Clinic use from 2014 to 2026

    • Figure Europe Dry Powder Inhaler Devices Market Size and Growth Rate of Household from 2014 to 2026

    • Figure Germany Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure UK Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure France Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Dry Powder Inhaler Devices Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Dry Powder Inhaler Devices Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Dry Powder Inhaler Devices

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dry Powder Inhaler Devices by Different Types from 2014 to 2026

    • Table Consumption Share of Dry Powder Inhaler Devices by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Single dose inhalers

    • Figure Market Size and Growth Rate of Multi-dose inhalers

    • Figure Market Size and Growth Rate of Storage dose inhalers

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Dry Powder Inhaler Devices by Different End-Users from 2014 to 2026

    • Table Consumption Share of Dry Powder Inhaler Devices by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital use

    • Figure Market Size and Growth Rate of Clinic use

    • Figure Market Size and Growth Rate of Household

    • Table Europe Dry Powder Inhaler Devices Production by Major Regions

    • Table Europe Dry Powder Inhaler Devices Production Share by Major Regions

    • Figure Europe Dry Powder Inhaler Devices Production Share by Major Countries and Regions in 2014

    • Table Europe Dry Powder Inhaler Devices Consumption by Major Regions

    • Table Europe Dry Powder Inhaler Devices Consumption Share by Major Regions

    • Table Germany Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table UK Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table France Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Italy Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Spain Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Poland Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Russia Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Switzerland Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Turkey Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Dry Powder Inhaler Devices Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Germany Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Germany Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Germany Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table UK Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table UK Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table UK Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table UK Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table France Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table France Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table France Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table France Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Italy Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Italy Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Italy Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Italy Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Spain Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Spain Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Spain Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Spain Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Poland Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Poland Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Poland Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Poland Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Russia Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Russia Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Russia Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Russia Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Switzerland Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Switzerland Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Switzerland Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Turkey Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Turkey Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Turkey Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Dry Powder Inhaler Devices Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Dry Powder Inhaler Devices Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Dry Powder Inhaler Devices Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Dry Powder Inhaler Devices Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Respira Therapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Respira Therapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Respira Therapeutics, Inc

    • Figure Revenue and Market Share Analysis of Respira Therapeutics, Inc

    • Table Product and Service Introduction of Respira Therapeutics, Inc

    • Table Company Profile and Development Status of AKELA Pharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AKELA Pharma Inc

    • Figure Sales and Growth Rate Analysis of AKELA Pharma Inc

    • Figure Revenue and Market Share Analysis of AKELA Pharma Inc

    • Table Product and Service Introduction of AKELA Pharma Inc

    • Table Company Profile and Development Status of Cipla Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cipla Inc

    • Figure Sales and Growth Rate Analysis of Cipla Inc

    • Figure Revenue and Market Share Analysis of Cipla Inc

    • Table Product and Service Introduction of Cipla Inc

    • Table Company Profile and Development Status of MannKind Corporation

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MannKind Corporation

    • Figure Sales and Growth Rate Analysis of MannKind Corporation

    • Figure Revenue and Market Share Analysis of MannKind Corporation

    • Table Product and Service Introduction of MannKind Corporation

    • Table Company Profile and Development Status of Aespira Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aespira Ltd

    • Figure Sales and Growth Rate Analysis of Aespira Ltd

    • Figure Revenue and Market Share Analysis of Aespira Ltd

    • Table Product and Service Introduction of Aespira Ltd

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Pharmaxis Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmaxis Limited

    • Figure Sales and Growth Rate Analysis of Pharmaxis Limited

    • Figure Revenue and Market Share Analysis of Pharmaxis Limited

    • Table Product and Service Introduction of Pharmaxis Limited

    • Table Company Profile and Development Status of Teva Pharmaceutical Industries Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Sales and Growth Rate Analysis of Teva Pharmaceutical Industries Ltd

    • Figure Revenue and Market Share Analysis of Teva Pharmaceutical Industries Ltd

    • Table Product and Service Introduction of Teva Pharmaceutical Industries Ltd

    • Table Company Profile and Development Status of Nanotherapeutics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanotherapeutics, Inc

    • Figure Sales and Growth Rate Analysis of Nanotherapeutics, Inc

    • Figure Revenue and Market Share Analysis of Nanotherapeutics, Inc

    • Table Product and Service Introduction of Nanotherapeutics, Inc

    • Table Company Profile and Development Status of Pharmaxis Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pharmaxis Limited

    • Figure Sales and Growth Rate Analysis of Pharmaxis Limited

    • Figure Revenue and Market Share Analysis of Pharmaxis Limited

    • Table Product and Service Introduction of Pharmaxis Limited

    • Table Company Profile and Development Status of Sandoz International GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International GmbH

    • Figure Sales and Growth Rate Analysis of Sandoz International GmbH

    • Figure Revenue and Market Share Analysis of Sandoz International GmbH

    • Table Product and Service Introduction of Sandoz International GmbH

    • Table Company Profile and Development Status of OPKO Health, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OPKO Health, Inc

    • Figure Sales and Growth Rate Analysis of OPKO Health, Inc

    • Figure Revenue and Market Share Analysis of OPKO Health, Inc

    • Table Product and Service Introduction of OPKO Health, Inc

    • Table Company Profile and Development Status of Shandong Jewim Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shandong Jewim Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Shandong Jewim Pharmaceutical

    • Figure Revenue and Market Share Analysis of Shandong Jewim Pharmaceutical

    • Table Product and Service Introduction of Shandong Jewim Pharmaceutical

    • Table Company Profile and Development Status of Bayer HealthCare AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer HealthCare AG

    • Figure Sales and Growth Rate Analysis of Bayer HealthCare AG

    • Figure Revenue and Market Share Analysis of Bayer HealthCare AG

    • Table Product and Service Introduction of Bayer HealthCare AG

    • Table Company Profile and Development Status of Novartis AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

    • Figure Sales and Growth Rate Analysis of Novartis AG

    • Figure Revenue and Market Share Analysis of Novartis AG

    • Table Product and Service Introduction of Novartis AG

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US